Literature DB >> 26487002

Disruption of REDD1 gene ameliorates sepsis-induced decrease in mTORC1 signaling but has divergent effects on proteolytic signaling in skeletal muscle.

Jennifer L Steiner1, Kristen T Crowell2, Scot R Kimball1, Charles H Lang3.   

Abstract

Sepsis-induced skeletal muscle atrophy and weakness are due in part to decreased mTORC1-mediated protein synthesis and increased proteolysis via the autophagy-lysosomal system and ubiquitin-proteasome pathway. The REDD1 (regulated in development and DNA damage-1) protein is increased in sepsis and can negatively regulate mTORC1 activity. However, the contribution of REDD1 to the sepsis-induced change in muscle protein synthesis and degradation has not been determined. Sepsis was produced by cecal ligation and puncture in female REDD1(-/-) or wild-type (WT) mice, and end points were assessed 24 h later in gastrocnemius; time-matched, pair-fed controls of each genotype were included. Sepsis increased REDD1 protein 300% in WT mice, whereas REDD1 was absent in REDD1(-/-) muscle. Sepsis decreased protein synthesis and phosphorylation of downstream targets of mTORC1 (S6K1 Thr(389), rpS6 Ser(240/244), 4E-BP1 Ser(65)) in WT but not REDD1(-/-) mice. However, Akt and PRAS40 phosphorylation was suppressed in both sham and septic muscle from REDD1(-/-) mice despite unaltered PDK1, PP2A, or TSC2 expression. Sepsis increased autophagy as indicated by decreased ULK1 Ser(757) phosphorylation and p62 abundance and increased LC3B-II/I in WT mice, whereas these changes were absent in septic REDD1(-/-) mice. Conversely, REDD1 deletion did not prevent the sepsis-induced decrease in IGF-I mRNA or the concomitant increase in IL-6, TNFα, MuRF1, and atrogin1 mRNA expression. Lastly, 5-day survival in a separate set of septic mice did not differ between WT and REDD1(-/-) mice. These data highlight the central role of REDD1 in regulating both protein synthesis and autophagy in skeletal muscle during sepsis.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  autophagy; cecal ligation and puncture; critical illness; mechanistic target of rapamycin complex 1; protein synthesis; proteolysis; rgulated in development and DNA damage-1

Mesh:

Substances:

Year:  2015        PMID: 26487002      PMCID: PMC4816198          DOI: 10.1152/ajpendo.00264.2015

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  55 in total

1.  Glycogen synthase kinase-3 is the predominant insulin-regulated eukaryotic initiation factor 2B kinase in skeletal muscle.

Authors:  L S Jefferson; J R Fabian; S R Kimball
Journal:  Int J Biochem Cell Biol       Date:  1999-01       Impact factor: 5.085

2.  TNF-binding protein ameliorates inhibition of skeletal muscle protein synthesis during sepsis.

Authors:  R Cooney; S R Kimball; R Eckman; G Maish; M Shumate; T C Vary
Journal:  Am J Physiol       Date:  1999-04

3.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

4.  Regulation of eIF-4E BP1 phosphorylation by mTOR.

Authors:  K Hara; K Yonezawa; M T Kozlowski; T Sugimoto; K Andrabi; Q P Weng; M Kasuga; I Nishimoto; J Avruch
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

5.  Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development.

Authors:  Takeshi Ueda; Rie Watanabe-Fukunaga; Hidehiro Fukuyama; Shigekazu Nagata; Rikiro Fukunaga
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

6.  Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle.

Authors:  Charles H Lang; Christine Silvis; Nobuko Deshpande; Gerald Nystrom; Robert A Frost
Journal:  Shock       Date:  2003-06       Impact factor: 3.454

Review 7.  Alteration of somatotropic function by proinflammatory cytokines.

Authors:  R A Frost; C H Lang
Journal:  J Anim Sci       Date:  2004       Impact factor: 3.159

8.  Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398.

Authors:  Gareth J Browne; Stephen G Finn; Christopher G Proud
Journal:  J Biol Chem       Date:  2004-01-05       Impact factor: 5.157

9.  Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle.

Authors:  G Tiao; J M Fagan; N Samuels; J H James; K Hudson; M Lieberman; J E Fischer; P O Hasselgren
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

10.  Implication of eIF2B rather than eIF4E in the regulation of global protein synthesis by amino acids in L6 myoblasts.

Authors:  S R Kimball; R L Horetsky; L S Jefferson
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

View more
  17 in total

1.  Inability to replete white adipose tissue during recovery phase of sepsis is associated with increased autophagy, apoptosis, and proteasome activity.

Authors:  Kristen T Crowell; David I Soybel; Charles H Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-01-18       Impact factor: 3.619

Review 2.  Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism.

Authors:  Bradley S Gordon; Jennifer L Steiner; David L Williamson; Charles H Lang; Scot R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-17       Impact factor: 4.310

3.  Restorative Mechanisms Regulating Protein Balance in Skeletal Muscle During Recovery From Sepsis.

Authors:  Kristen T Crowell; David I Soybel; Charles H Lang
Journal:  Shock       Date:  2017-04       Impact factor: 3.454

4.  A time course for markers of protein synthesis and degradation with hindlimb unloading and the accompanying anabolic resistance to refeeding.

Authors:  Paul A Roberson; Kevin L Shimkus; Jaclyn E Welles; Dandan Xu; Abigale L Whitsell; Eric M Kimball; Leonard S Jefferson; Scot R Kimball
Journal:  J Appl Physiol (1985)       Date:  2020-05-14

5.  Binge alcohol disrupts skeletal muscle core molecular clock independent of glucocorticoids.

Authors:  Abigail L Tice; Joseph A Laudato; Michael L Rossetti; Christopher A Wolff; Karyn A Esser; Choogon Lee; Charles H Lang; Cynthia Vied; Bradley S Gordon; Jennifer L Steiner
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-09-20       Impact factor: 4.310

6.  Myostatin deficiency not only prevents muscle wasting but also improves survival in septic mice.

Authors:  Masayuki Kobayashi; Shingo Kasamatsu; Shohei Shinozaki; Shingo Yasuhara; Masao Kaneki
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

7.  Marginal dietary zinc deprivation augments sepsis-induced alterations in skeletal muscle TNF-α but not protein synthesis.

Authors:  Kristen T Crowell; Shannon L Kelleher; David I Soybel; Charles H Lang
Journal:  Physiol Rep       Date:  2016-11

8.  Burn-induced muscle metabolic derangements and mitochondrial dysfunction are associated with activation of HIF-1α and mTORC1: Role of protein farnesylation.

Authors:  Harumasa Nakazawa; Kazuhiro Ikeda; Shohei Shinozaki; Masayuki Kobayashi; Yuichi Ikegami; Ming Fu; Tomoyuki Nakamura; Shingo Yasuhara; Yong-Ming Yu; J A Jeevendra Martyn; Ronald G Tompkins; Kentaro Shimokado; Tomoko Yorozu; Hideki Ito; Satoshi Inoue; Masao Kaneki
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

9.  Differential regulation of muscle protein turnover in response to emphysema and acute pulmonary inflammation.

Authors:  Judith J M Ceelen; Annemie M W J Schols; Stefan J van Hoof; Chiel C de Theije; Frank Verhaegen; Ramon C J Langen
Journal:  Respir Res       Date:  2017-05-02

Review 10.  Is REDD1 a Metabolic Éminence Grise?

Authors:  Christopher Lipina; Harinder S Hundal
Journal:  Trends Endocrinol Metab       Date:  2016-09-06       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.